Symposium 20: Pharmacological treatment of the patient with Non-Alcoholic Fatty Disease (NAFLD)
2022
Karina Fuentes
EGHNA, has high prevalence and is strongly related to obesity and diabetes, with great impact at the health level since it is one of the largest causes of end-stage liver disease and transplantation. There are no specific drugs approved for its treatment, only lifestyle changes show benefits: food plan, based on the Mediterranean diet (high in olive oil, fruits, vegetables, legumes, nuts and fish) weight reduction (5-10%) and exercises (aerobic 3 times a week or resistance 2 times a week).
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
Revista de la Sociedad Argentina de Diabetes
卷
56
期
3Sup
页码
108
- 108
ISSN
0325-5247 | 2346-9420
出版者
Sello Editorial Lugones
其它主题
Tratamiento
语言
西班牙语; 卡斯蒂利亚语
2024-12-11
2025-09-23
DOAJ